We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Kirkland, Wachtell Steer Bristol-Myers’ $74B Celgene Buy

Law360 (January 3, 2019, 7:57 AM EST) -- Bristol-Myers Squibb, led by Kirkland & Ellis LLP, said Thursday it will take over New Jersey-based Celgene, advised by Wachtell Lipton Rosen & Katz, in a $74 billion cash-and-stock deal aimed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.